08 June 2023>: Clinical Research
Analysis of Factors Related to Type 2 Diabetic Peripheral Neuropathy Based on Flash Glucose Monitoring System
Qian Ma ABCDEF*DOI: 10.12659/MSM.939157
Med Sci Monit 2023; 29:e939157
Table 3 Spearman correlation analysis between clinical variables and DPN (n=150).
Variable | r | p |
---|---|---|
Gender (male/female) | −0.019 | 0.733 |
Age (years) | 0.011 | 0.846 |
Diabetes course (years) | 0.185 | 0.001 |
smoking n (%) | 0.225 | 0.000 |
BMI (Kg/m) | 0.044 | 0.429 |
SBP (mmHg) | −0.01 | 0.860 |
DBP (mmHg) | −0.01 | 0.852 |
FBG (mmol/L) | 0.119 | 0.032 |
2hPG (mmol/L) | 0.142 | 0.010 |
HbA1c (%) | 0.142 | 0.010 |
HOMA-IR | 0.276 | 0.000 |
TC (mmol/L) | 0.070 | 0.206 |
TG (mmol/L) | −0.095 | 0.088 |
HDL-C (mmol/L) | 0.099 | 0.076 |
LDL-C (mmol/L) | 0.093 | 0.095 |
MBG (mmol/L) | 0.202 | 0.000 |
SD (mmol/L) | 0.421 | 0.000 |
CV (%) | 0.381 | 0.000 |
MAGE (mmol/L) | 0.275 | 0.000 |
MODD (mmol/L) | 0.333 | 0.000 |
TAR (≥10.0 mmol/L) (%) | 0.326 | 0.000 |
TIR (3.9–10.0 mmol/L) (%) | −0.373 | 0.000 |
TBR (≤3.9mmol/L) (%) | 0.053 | 0.338 |